0005
Samil Pharmaceutical Co.,Ltd 000520
Market Closed
8 Oct, 06:30
KRX SM KRX SM Primary 
XSHE ₩
17,060. 00
+900
+5.57%
₩
351.68B Market Cap
- P/E Ratio
320% Div Yield
916,523 Volume
- Eps
₩ 16,160.00
Previous Close Day Range
16,030 17,700
Year Range
5,690 17,700
000520 Chart
Samil Pharmaceutical Co.,Ltd Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | - CEO | KRX SM Exchange | KR7000520007 ISIN |
| South Korea Country | 586 Employees | - Last Dividend | 24 Mar 2023 Last Split | - IPO Date |
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
Contact Information
Address: 155 Hyoryeong-Ro
Phone: 82 2 520 0300
Website: https://www.samil-pharm.com